The role of chemokines in vertebrate physiology and disease: a concise review

 

 

1. Murphy K, Travers P, Walport M, Janeway C (2012) Janeway's immunobiology, 8th ed. Garland Science ; London : Taylor & Francis [distributor], London

 2. Murphy K, Weaver C (2016) Janeway's Immunobiology, 9th Edition. Garland Science. https://doi.org/10.1201/9781315533247

3. Koch AE, Polverini PJ, Kunkel SL, Harlow LA, DiPietro LA, Elner VM, Elner SG, Strieter RM (1992) Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 258:1798-1801 . https://doi.org/10.1126/science.1281554

4. Nagasawa T, Hirota S, Tachibana K, Takakura N, Nishikawa S, Kitamura Y, Yoshida N, Kikutani H, Kishimoto T (1996) Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature 382:635-638 . https://doi.org/10.1038/382635a0

5. Zou YR, Kottmann AH, Kuroda M, Taniuchi I, Littman DR (1998) Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 393:595-599 . https://doi.org/10.1038/31269

6. Martin TA (2001) Interleukin-8 and Angiogenesis. In: Snyder CR, Jiang WG, Matsumoto K, Nakamura T (eds) Growth Factors and their Receptors in Cancer Metastasis. Springer Netherlands, Dordrecht, pp 51-65. https://doi.org/10.1007/0-306-48399-8_3

7. Müller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, Barrera JL, Mohar A, Verástegui E, Zlotnik A (2001) Involvement of chemokine receptors in breast cancer metastasis. Nature 410:50-56 . https://doi.org/10.1038/35065016

8. Chensue SW (2001) Molecular Machinations: Chemokine Signals in Host-Pathogen Interactions. Clin Microbiol Rev 14:821-835 . https://doi.org/10.1128/CMR.14.4.821-835.2001

9. Doitsidou M, Reichman-Fried M, Stebler J, Köprunner M, Dörries J, Meyer D, Esguerra CV, Leung T, Raz E (2002) Guidance of Primordial Germ Cell Migration by the Chemokine SDF-1. Cell 111:647-659 . https://doi.org/10.1016/S0092-8674(02)01135-2

10. Wang J, Knaut H (2014) Chemokine signaling in development and disease. Development 141:4199-4205 .

https://doi.org/10.1242/dev.101071

11. Knorr M, Münzel T, Wenzel P (2014) Interplay of NK cells and monocytes in vascular inflammation and myocardial infarction. Front Physiol 5: https://doi.org/10.3389/fphys.2014.00295

12. De Filippo K, Dudeck A, Hasenberg M, Nye E, van Rooijen N, Hartmann K, Gunzer M, Roers A, Hogg N (2013) Mast cell and macrophage chemokines CXCL1/CXCL2 control the early stage of neutrophil recruitment during tissue inflammation. Blood 121:4930-4937 . https://doi.org/10.1182/blood-2013-02-486217

13. Tamagawa-Mineoka R, Katoh N, Kishimoto S (2009) Platelets play important roles in the late phase of the immediate hypersensitivity reaction. J Allergy Clin Immunol 123:581-587.e9 . https://doi.org/10.1016/j.jaci.2008.12.1114

14. Tamagawa-Mineoka R (2015) Important roles of platelets as immune cells in the skin. J Dermatol Sci 77:93-101 .

https://doi.org/10.1016/j.jdermsci.2014.10.003

15. Kunkel EJ, Kim CH, Lazarus NH, Vierra MA, Soler D, Bowman EP, Butcher EC (2003) CCR10 expression is a common feature of circulating and mucosal epithelial tissue IgA Ab-secreting cells. J Clin Invest 111:1001-1010 .

https://doi.org/10.1172/JCI17244

16. Wilson E, Butcher EC (2004) CCL28 Controls Immunoglobulin (Ig)A Plasma Cell Accumulation in the Lactating Mammary Gland and IgA Antibody Transfer to the Neonate. J Exp Med 200:805-809 . https://doi.org/10.1084/jem.20041069

17. Morteau O, Gerard C, Lu B, Ghiran S, Rits M, Fujiwara Y, Law Y, Distelhorst K, Nielsen EM, Hill ED, Kwan R, Lazarus NH, Butcher EC, Wilson E (2008) An indispensable role for the chemokine receptor CCR10 in IgA antibody-secreting cell accumulation. J Immunol Baltim Md 1950 181:6309-6315 . https://doi.org/10.4049/jimmunol.181.9.6309

18. LIU G-X, LAN J, SUN Y, HU Y-J, JIANG G-S (2012) Expression of the chemokine CCL28 in pleomorphic adenoma and adenolymphoma of the human salivary glands. Exp Ther Med 4:65-69 . https://doi.org/10.3892/etm.2012.544

19. Vazquez MI, Catalan-Dibene J, Zlotnik A (2015) B cells responses and cytokine production are regulated by their immune microenvironment. Cytokine 74:318-326 . https://doi.org/10.1016/j.cyto.2015.02.007

20. Simon CMFrcp (2013) Underwood's Pathology: a Clinical Approach, 6 edition. Churchill Livingstone, Edinburgh

 21. Vinay KMMFrcp, K AM Abul, C AMP Jon (2017) Robbins Basic Pathology, 10 edition. Elsevier, Philadelphia, Pennsylvania

22. Gillitzer R, Goebeler M (2001) Chemokines in cutaneous wound healing. J Leukoc Biol 69:513-521 . https://doi.org/10.1189/jlb.69.4.513

23. Ishida Y, Gao J-L, Murphy PM (2008) Chemokine Receptor CX3CR1 Mediates Skin Wound Healing by Promoting Macrophage and Fibroblast Accumulation and Function. J Immunol 180:569-579 . https://doi.org/10.4049/jimmunol.180.1.569

24. Devalaraja RM, Nanney LB, Qian Q, Du J, Yu Y, Devalaraja MN, Richmond A (2000) Delayed Wound Healing in CXCR2 Knockout Mice. J Invest Dermatol 115:234-244 . https://doi.org/10.1046/j.1523-1747.2000.00034.x

25. Michel G, Kemény L, Peter RU, Beetz A, Ried C, Arenberger P, Ruzicka T (1992) Interleukin-8 receptor-mediated chemotaxis of normal human epidermal cells. FEBS Lett 305:241-243 . https://doi.org/10.1016/0014-5793(92)80677-9

26. Tuschil A, Lam C, Haslberger A, Lindley I (1992) Interleukin-8 stimulates calcium transients and promotes epidermal cell proliferation. J Invest Dermatol 99:294-298 . https://doi.org/10.1111/1523-1747.ep12616634

27. Gyulai R, Hunyadi J, Kenderessy‐Szabó A, Kemény L, Dobozy A (1994) Chemotaxis of freshly separated and cultured human keratinocytes. Clin Exp Dermatol 19:309-311 . https://doi.org/10.1111/j.1365-2230.1994.tb01201.x

28. Rennekampff HO, Hansbrough JF, Kiessig V, Doré C, Sticherling M, Schröder JM (2000) Bioactive interleukin-8 is expressed in wounds and enhances wound healing. J Surg Res 93:41-54 . https://doi.org/10.1006/jsre.2000.5892

29. Niu G, Wright KL, Huang M, Song L, Haura E, Turkson J, Zhang S, Wang T, Sinibaldi D, Coppola D, Heller R, Ellis LM, Karras J, Bromberg J, Pardoll D, Jove R, Yu H (2002) Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis. Oncogene 21:2000-8 https://doi.org/10.1038/sj.onc.1205260

30. Ogata H, Sekikawa A, Yamagishi H, Ichikawa K, Tomita S, Imura J, Ito Y, Fujita M, Tsubaki M, Kato H, Fujimori T, Fukui H (2010) GROα promotes invasion of colorectal cancer cells. Oncol Rep 24:1479-86. https://doi.org/10.3892/or_00001008

31. Miyake M, Lawton A, Goodison S, Urquidi V, Gomes-Giacoia E, Zhang G, Ross S, Kim J, Rosser CJ (2013) Chemokine (C-X-C) ligand 1 (CXCL1) protein expression is increased in aggressive bladder cancers. BMC Cancer 13:322. https://doi.org/10.1186/1471-2407-13-322

32. Quintás-Cardama A, Verstovsek S (2013) Molecular pathways: Jak/STAT pathway: mutations, inhibitors, and resistance. Clin Cancer Res 19:1933-40. https://doi.org/10.1158/1078-0432.CCR-12-0284

33. Katoh H, Wang D, Daikoku T, Sun H, Dey SK, Dubois RN (2013) CXCR2-expressing myeloid-derived suppressor cells are essential to promote colitis-associated tumorigenesis. Cancer Cell 24:631-44. https://doi.org/10.1016/j.ccr.2013.10.009

34. Wei ZW, Xia GK, Wu Y, Chen W, Xiang Z, Schwarz RE, Brekken RA, Awasthi N, He YL, Zhang CH (2015) CXCL1 promotes tumor growth through VEGF pathway activation and is associated with inferior survival in gastric cancer. Cancer Lett 359:335-43. https://doi.org/10.1016/j.canlet.2015.01.033

35. Xu J, Zhang C, He Y, Wu H, Wang Z, Song W, Li W, He W, Cai S, Zhan W (2012) Lymphatic endothelial cell-secreted CXCL1 stimulates lymphangiogenesis and metastasis of gastric cancer. Int J Cancer 130:787-97. https://doi.org/10.1002/ijc.26035

36. Wang D, Yang W, Du J, Devalaraja MN, Liang P, Matsumoto K, Tsubakimoto K, Endo T, Richmond A (2000) MGSA/GRO-mediated melanocyte transformation involves induction of Ras expression. Oncogene 19:4647-59. https://doi.org/10.1038/sj.onc.1203820

37. Yang G, Rosen DG, Zhang Z, Bast RC, Mills GB, Colacino JA, Mercado-Uribe I, Liu J (2006) The chemokine growth-regulated oncogene 1 (Gro-1) links RAS signaling to the senescence of stromal fibroblasts and ovarian tumorigenesis. Proc Natl Acad Sci U A 103:16472-7. https://doi.org/10.1073/pnas.0605752103

38. Dong YL, Kabir SM, Lee ES, Son DS (2013) CXCR2-driven ovarian cancer progression involves upregulation of proinflammatory chemokines by potentiating NF-κB activation via EGFR-transactivated Akt signaling. PLoS One 8:e83789. https://doi.org/10.1371/journal.pone.0083789

39. Ijichi H, Chytil A, Gorska AE, Aakre ME, Bierie B, Tada M, Mohri D, Miyabayashi K, Asaoka Y, Maeda S, Ikenoue T, Tateishi K, Wright CV, Koike K, Omata M, Moses HL (2011) Inhibiting Cxcr2 disrupts tumor-stromal interactions and improves survival in a mouse model of pancreatic ductal adenocarcinoma. J Clin Invest 121:4106-17. https://doi.org/10.1172/JCI42754

40. Oue E, Lee JW, Sakamoto K, Iimura T, Aoki K, Kayamori K, Michi Y, Yamashiro M, Harada K, Amagasa T, Yamaguchi A (2012) CXCL2 synthesized by oral squamous cell carcinoma is involved in cancer-associated bone destruction. Biochem Biophys Res Commun 424:456-61. https://doi.org/10.1016/j.bbrc.2012.06.132

41. Hardaway AL, Herroon MK, Rajagurubandara E, Podgorski I (2015) Marrow adipocyte-derived CXCL1 and CXCL2 contribute to osteolysis in metastatic prostate cancer. Clin Exp Metastasis. https://doi.org/10.1007/s10585-015-9714-5

42. Bachmeier B, Nerlich AG, Iancu CM, Cilli M, Schleicher E, Vené R, Dell'Eva R, Jochum M, Albini A, Pfeffer U (2007) The chemopreventive polyphenol Curcumin prevents hematogenous breast cancer metastases in immunodeficient mice. Cell Physiol Biochem 19:137-52. https://doi.org/10.1159/000099202

43. Killian PH, Kronski E, Michalik KM, Barbieri O, Astigiano S, Sommerhoff CP, Pfeffer U, Nerlich AG, Bachmeier BE (2012) Curcumin inhibits prostate cancer metastasis in vivo by targeting the inflammatory cytokines CXCL1 and -2. Carcinogenesis 33:2507-19. https://doi.org/10.1093/carcin/bgs312

44. Kronski E, Fiori ME, Barbieri O, Astigiano S, Mirisola V, Killian PH, Bruno A, Pagani A, Rovera F, Pfeffer U, Sommerhoff CP, Noonan DM, Nerlich AG, Fontana L, Bachmeier BE (2014) miR181b is induced by the chemopreventive polyphenol curcumin and inhibits breast cancer metastasis via down-regulation of the inflammatory cytokines CXCL1 and -2. Mol Oncol 8:581-95. https://doi.org/10.1016/j.molonc.2014.01.005

45. Owen JL, Criscitiello MF, Libreros S, Garcia-Areas R, Guthrie K, Torroella-Kouri M, Iragavarapu-Charyulu V (2011) Expression of the inflammatory chemokines CCL2, CCL5 and CXCL2 and the receptors CCR1-3 and CXCR2 in T lymphocytes from mammary tumor-bearing mice. Cell Immunol 270:172-82. https://doi.org/10.1016/j.cellimm.2011.05.004

46. Gardai SJ, McPhillips KA, Frasch SC, Janssen WJ, Starefeldt A, Murphy-Ullrich JE, Bratton DL, Oldenborg PA, Michalak M, Henson PM (2005) Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte. Cell 123:321-34. https://doi.org/10.1016/j.cell.2005.08.032

47. Obeid M, Tesniere A, Ghiringhelli F, Fimia GM, Apetoh L, Perfettini JL, Castedo M, Mignot G, Panaretakis T, Casares N, Métivier D, Larochette N, van Endert P, Ciccosanti F, Piacentini M, Zitvogel L, Kroemer G (2007) Calreticulin exposure dictates the immunogenicity of cancer cell death. Nat Med 13:54-61. https://doi.org/10.1038/nm1523

48. Sukkurwala AQ, Martins I, Wang Y, Schlemmer F, Ruckenstuhl C, Durchschlag M, Michaud M, Senovilla L, Sistigu A, Ma Y, Vacchelli E, Sulpice E, Gidrol X, Zitvogel L, Madeo F, Galluzzi L, Kepp O, Kroemer G (2014) Immunogenic calreticulin exposure occurs through a phylogenetically conserved stress pathway involving the chemokine CXCL8. Cell Death Differ 21:59-68. https://doi.org/10.1038/cdd.2013.73

49. Gao JL, Murphy PM (1994) Human cytomegalovirus open reading frame US28 encodes a functional beta chemokine receptor. J Biol Chem 269:28539-42. https://doi.org/10.1016/S0021-9258(19)61936-8

50. Damon I, Murphy PM, Moss B (1998) Broad spectrum chemokine antagonistic activity of a human poxvirus chemokine homolog. Proc Natl Acad Sci U A 95:6403-7. https://doi.org/10.1073/pnas.95.11.6403

51. Chen S, Bacon KB, Li L, Garcia GE, Xia Y, Lo D, Thompson DA, Siani MA, Yamamoto T, Harrison JK, Feng L (1998) In vivo inhibition of CC and CX3C chemokine-induced leukocyte infiltration and attenuation of glomerulonephritis in Wistar-Kyoto (WKY) rats by vMIP-II. J Exp Med 188:193-8. https://doi.org/10.1084/jem.188.1.193

52. Vink C, Beisser PS, Bruggeman CA (1999) Molecular mimicry by cytomegaloviruses. Function of cytomegalovirus-encoded homologues of G protein-coupled receptors, MHC class I heavy chains and chemokines. Intervirology 42:342-9. https://doi.org/10.1159/000053970

53. Milne RS, Mattick C, Nicholson L, Devaraj P, Alcami A, Gompels UA (2000) RANTES binding and down-regulation by a novel human herpesvirus-6 beta chemokine receptor. J Immunol 164:2396-404. https://doi.org/10.4049/jimmunol.164.5.2396

54. Kotwal GJ (2000) Poxviral mimicry of complement and chemokine system components: what's the end game? Immunol Today 21:242-8. https://doi.org/10.1016/S0167-5699(00)01606-6

55. Murphy PM (2001) Viral exploitation and subversion of the immune system through chemokine mimicry. Nat Immunol 2:116-22. https://doi.org/10.1038/84214

56. Tripp RA, Jones LP, Haynes LM, Zheng H, Murphy PM, Anderson LJ (2001) CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein. Nat Immunol 2:732-8. https://doi.org/10.1038/90675

57. Alcami A (2003) Viral mimicry of cytokines, chemokines and their receptors. Nat Rev Immunol 3:36-50. https://doi.org/10.1038/nri980

58. Bryant NA, Davis-Poynter N, Vanderplasschen A, Alcami A (2003) Glycoprotein G isoforms from some alphaherpesviruses function as broad-spectrum chemokine binding proteins. EMBO J 22:833-46. https://doi.org/10.1093/emboj/cdg092

59. Lau EK, Allen S, Hsu AR, Handel TM (2004) Chemokine-receptor interactions: GPCRs, glycosaminoglycans and viral chemokine binding proteins. Adv Protein Chem 68:351-91. https://doi.org/10.1016/S0065-3233(04)68010-7

60. Rosenkilde MM (2005) Virus-encoded chemokine receptors--putative novel antiviral drug targets. Neuropharmacology 48:1-13. https://doi.org/10.1016/j.neuropharm.2004.09.017

61. Epperson ML, Lee CA, Fremont DH (2012) Subversion of cytokine networks by virally encoded decoy receptors. Immunol Rev 250:199-215. https://doi.org/10.1111/imr.12009

62. McSharry BP, Avdic S, Slobedman B (2012) Human cytomegalovirus encoded homologs of cytokines, chemokines and their receptors: roles in immunomodulation. Viruses 4:2448-70. https://doi.org/10.3390/v4112448

63. Wu L, Gerard NP, Wyatt R, Choe H, Parolin C, Ruffing N, Borsetti A, Cardoso AA, Desjardin E, Newman W, Gerard C, Sodroski J (1996) CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5. Nature 384:179-183 . https://doi.org/10.1038/384179a0.

64. Liao F, Alkhatib G, Peden KWC, Sharma G, Berger EA, Farber JM (1997) STRL33, A Novel Chemokine Receptor-like Protein, Functions as a Fusion Cofactor for Both Macrophage-tropic and T Cell Line-tropic HIV-1. J Exp Med 185:2015-2023. https://doi.org/10.1084/jem.185.11.2015

65. Farber JM (1998) Chemokines, lymphocytes, and HIV. Braz J Med Biol Res 31:11-17 . https://doi.org/10.1590/S0100-879X1998000100002

66. Rizzuto CD, Wyatt R, Hernández-Ramos N, Sun Y, Kwong PD, Hendrickson WA, Sodroski J (1998) A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding. Science 280:1949-1953. https://doi.org/10.1126/science.280.5371.1949

67. Wyatt R, Sodroski J (1998) The HIV-1 Envelope Glycoproteins: Fusogens, Antigens, and Immunogens. Science 280:1884-1888 . https://doi.org/10.1126/science.280.5371.1884

68. Efremov R, Truong M-J, Darcissac ECA, Zeng J, Grau O, Vergoten G, Debard C, Capron A, Bahr GM (1999) Human chemokine receptors CCR5, CCR3 and CCR2B share common polarity motif in the first extracellular loop with other human G-protein coupled receptors. Eur J Biochem 263:746-756 . https://doi.org/10.1046/j.1432-1327.1999.00553.x

69. Rowland-Jones S (1999) The role of chemokine receptors in HIV infection. Sex Transm Infect 75:148-151. https://doi.org/10.1136/sti.75.3.148

70. Suresh P, Wanchu A (2006) Chemokines and chemokine receptors in HIV infection: role in pathogenesis and therapeutics. J Postgrad Med 52:210-217.

 71. Nedellec R, Coetzer M, Shimizu N, Hoshino H, Polonis VR, Morris L, Mårtensson UEA, Binley J, Overbaugh J, Mosier DE (2009) Virus Entry via the Alternative Coreceptors CCR3 and FPRL1 Differs by Human Immunodeficiency Virus Type 1 Subtype. J Virol 83:8353-8363 . https://doi.org/10.1128/JVI.00780-09

72. Wang Z, Shang H, Jiang Y (2017) Chemokines and Chemokine Receptors: Accomplices for Human Immunodeficiency Virus Infection and Latency. Front Immunol 8: . https://doi.org/10.3389/fimmu.2017.01274

73. Choe H, Farzan M, Sun Y, Sullivan N, Rollins B, Ponath PD, Wu L, Mackay CR, LaRosa G, Newman W, Gerard N, Gerard C, Sodroski J (1996) The β-Chemokine Receptors CCR3 and CCR5 Facilitate Infection by Primary HIV-1 Isolates. Cell 85:1135-1148 . https://doi.org/10.1016/S0092-8674(00)81313-6

74. Doranz BJ, Rucker J, Yi Y, Smyth RJ, Samson M, Peiper SC, Parmentier M, Collman RG, Doms RW (1996) A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 85:1149-1158 . https://doi.org/10.1016/s0092-8674(00)81314-8

75. Deng HK, Unutmaz D, KewalRamani VN, Littman DR (1997) Expression cloning of new receptors used by simian and human immunodeficiency viruses. Nature 388:296-300 . https://doi.org/10.1038/40894

76. Louisirirotchanakul S, Liu H, Roongpisuthipong A, Nakayama E, Takebe Y, Shioda T (2002) Genetic Analysis of HIV-1 Discordant Couples in Thailand: Association of CCR2 64I Homozygosity With HIV-1-Negative Status. J Acquir Immune Defic Syndr 1999 29:314-5 . https://doi.org/10.1097/00042560-200203010-00014

77. Furci L, Scarlatti G, Burastero S, Tambussi G, Colognesi C, Quillent C, Longhi R, Loverro P, Borgonovo B, Gaffi D, Carrow E, Malnati M, Lusso P, Siccardi AG, Lazzarin A, Beretta A (1997) Antigen-driven C-C Chemokine-mediated HIV-1 Suppression by CD4+ T Cells from Exposed Uninfected Individuals Expressing the Wild-type CCR-5 Allele. J Exp Med 186:455-460. https://doi.org/10.1084/jem.186.3.455

78. Nedoszytko B, sokolowska-wojdylo M, Ruckemann-Dziurdzińska K, Roszkiewicz J, Nowicki R (2014) Chemokines and cytokines network in the pathogenesis of the inflammatory skin diseases: Atopic dermatitis, psoriasis and skin mastocytosis. Postȩpy Dermatol Alergol 31:84-91 . https://doi.org/10.5114/pdia.2014.40920

79. Zhou X, Krueger JG, Kao M-CJ, Lee E, Du F, Menter A, Wong WH, Bowcock AM (2003) Novel mechanisms of T-cell and dendritic cell activation revealed by profiling of psoriasis on the 63,100-element oligonucleotide array. Physiol Genomics 13:69-78 . https://doi.org/10.1152/physiolgenomics.00157.2002

80. Nomura I, Gao B, Boguniewicz M, Darst MA, Travers JB, Leung DYM (2003) Distinct patterns of gene expression in the skin lesions of atopic dermatitis and psoriasis: A gene microarray analysis. J Allergy Clin Immunol 112:1195-1202 . https://doi.org/10.1016/j.jaci.2003.08.049

81. Martynowicz H, Janus A, Nowacki D, Mazur G (2014) The Role of Chemokines in Hypertension. Adv Clin Exp Med Off Organ Wroclaw Med Univ 23:319-325 . https://doi.org/10.17219/acem/37123

82. Rudemiller NP, Crowley SD (2017) The role of chemokines in hypertension and consequent target organ damage. Pharmacol Res 119:404-411 . https://doi.org/10.1016/j.phrs.2017.02.026

83. Tanase DM, Gosav EM, Radu S, Ouatu A, Rezus C, Ciocoiu M, Costea CF, Floria M (2019) Arterial Hypertension and Interleukins: Potential Therapeutic Target or Future Diagnostic Marker? In: Int. J. Hypertens. https://www.hindawi.com/journals/ijhy/2019/3159283/. Accessed 25 Sep 2020 . https://doi.org/10.1155/2019/3159283

84. Chistiakov DA, Orekhov AN, Sobenin IA, Bobryshev YV (2014) Plasmacytoid dendritic cells: development, functions, and role in atherosclerotic inflammation. Front Physiol 5: . https://doi.org/10.3389/fphys.2014.00279

85. Marx N, Mach F, Sauty A, Leung JH, Sarafi MN, Ransohoff RM, Libby P, Plutzky J, Luster AD (2000) Peroxisome Proliferator-Activated Receptor-γ Activators Inhibit IFN-γ-Induced Expression of the T Cell-Active CXC Chemokines IP-10, Mig, and I-TAC in Human Endothelial Cells. J Immunol Baltim Md 1950 164:6503-6508. https://doi.org/10.4049/jimmunol.164.12.6503

86. Rotondi M, Chiovato L, Romagnani S, Serio M, Romagnani P (2007) Role of Chemokines in Endocrine Autoimmune Diseases. Endocr Rev 28:492-520 . https://doi.org/10.1210/er.2006-0044

87. Kimura H, Caturegli P (2007) Chemokine orchestration of autoimmune thyroiditis. Thyroid Off J Am Thyroid Assoc 17:1005-1011 . https://doi.org/10.1089/thy.2007.0267

88. Ferrari SM, Fallahi P, Vita R, Antonelli A, Benvenga S (2015) Peroxisome Proliferator-Activated Receptor-γ in Thyroid Autoimmunity. In: PPAR Res. https://www.hindawi.com/journals/ppar/2015/232818/. Accessed 25 Sep 2020. https://doi.org/10.1155/2015/232818

89. Ferrari SM, Ruffilli I, Elia G, Ragusa F, Paparo SR, Patrizio A, Mazzi V, Antonelli A, Fallahi P (2019) Chemokines in hyperthyroidism. J Clin Transl Endocrinol 16: . https://doi.org/10.1016/j.jcte.2019.100196

90. Domberg J, Chao L, Papewalis C, Pfleger C, Xu K, Willenberg HS, Hermsen D, Scherbaum WA, Schloot NC, Schott M (2008) Circulating Chemokines in Patients with Autoimmune Thyroid Diseases. Horm Metab Res 40:416-421. https://doi.org/10.1055/s-2008-1073151

91. Liu C, Cui G, Zhu M, Kang X, Guo H (2014) Neuroinflammation in Alzheimer's disease: chemokines produced by astrocytes and chemokine receptors. Int J Clin Exp Pathol 7:8342-8355

 92. Alsadany MA, Shehata HH, Mohamad MI, Mahfouz RG (2013) Histone Deacetylases Enzyme, Copper, and IL-8 Levels in Patients With Alzheimer's Disease. Am J Alzheimers Dis Dementiasr 28:54-61 . https://doi.org/10.1177/1533317512467680

93. Galimberti D, Schoonenboom N, Scheltens P, Fenoglio C, Venturelli E, Pijnenburg Y a. L, Bresolin N, Scarpini E (2006) Intrathecal chemokine levels in Alzheimer disease and frontotemporal lobar degeneration. Neurology 66:146-147 . https://doi.org/10.1212/01.wnl.0000191324.08289.9d

94. Venturelli E, Galimberti D, Fenoglio C, Lovati C, Finazzi D, Guidi I, Corrà B, Scalabrini D, Clerici F, Mariani C, Forloni G, Bresolin N, Scarpini E (2006) Candidate gene analysis of IP-10 gene in patients with Alzheimer's disease. Neurosci Lett 404:217-221 . https://doi.org/10.1016/j.neulet.2006.05.054

95. Tripathy D, Thirumangalakudi L, Grammas P (2010) RANTES upregulation in the Alzheimer's disease brain: a possible neuroprotective role. Neurobiol Aging 31:8-16 . https://doi.org/10.1016/j.neurobiolaging.2008.03.009

96. Kester MI, van der Flier WM, Visser A, Blankenstein MA, Scheltens P, Oudejans CB (2011) Decreased mRNA expression of CCL5 [RANTES] in Alzheimer's disease blood samples. Clin Chem Lab Med 50:61-65. https://doi.org/10.1515/CCLM.2011.731

97. Laske C, Stellos K, Stransky E, Seizer P, Akcay O, Eschweiler GW, Leyhe T, Gawaz M (2008) Decreased plasma and cerebrospinal fluid levels of stem cell factor in patients with early Alzheimer's disease. J Alzheimers Dis JAD 15:451-460 . https://doi.org/10.3233/jad-2008-15311

98. van der Meer P, Ulrich AM, Gonźalez-Scarano F, Lavi E (2000) Immunohistochemical analysis of CCR2, CCR3, CCR5, and CXCR4 in the human brain: potential mechanisms for HIV dementia. Exp Mol Pathol 69:192-201 . https://doi.org/10.1006/exmp.2000.2336

99. Williams JL, Holman DW, Klein RS (2014) Chemokines in the balance: maintenance of homeostasis and protection at CNS barriers. Front Cell Neurosci 8: . https://doi.org/10.3389/fncel.2014.00154

100. Deverman BE, Patterson PH (2009) Cytokines and CNS Development. Neuron 64:61-78. https://doi.org/10.1016/j.neuron.2009.09.002

101. Harrison JK, Jiang Y, Chen S, Xia Y, Maciejewski D, McNamara RK, Streit WJ, Salafranca MN, Adhikari S, Thompson DA, Botti P, Bacon KB, Feng L (1998) Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia. Proc Natl Acad Sci 95:10896-10901. https://doi.org/10.1073/pnas.95.18.10896

102. Huising MO, Meulen T van der, Flik G, Kemenade BMLV (2004) Three novel carp CXC chemokines are expressed early in ontogeny and at nonimmune sites. Eur J Biochem 271:4094-4106 . https://doi.org/10.1111/j.1432-1033.2004.04347.x

103. Banisadr G, Bhattacharyya B, Belmadani A, Izen SC, Ren D, Tran PB, Miller RJ (2011) The chemokine BRAK/CXCL14 regulates synaptic transmission in the adult mouse dentate gyrus stem cell niche. J Neurochem 119:1173-1182 . https://doi.org/10.1111/j.1471-4159.2011.07509.x

104. Kokovay E, Goderie S, Wang Y, Lotz S, Lin G, Sun Y, Roysam B, Shen Q, Temple S (2010) Adult SVZ lineage cells home to and leave the vascular niche via differential responses to SDF1/CXCR4 signaling. Cell Stem Cell 7:163-173 . https://doi.org/10.1016/j.stem.2010.05.019

105. Fan Q, Gayen M, Singh N, Gao F, He W, Hu X, Tsai L-H, Yan R (2019) The intracellular domain of CX3CL1 regulates adult neurogenesis and Alzheimer's amyloid pathology. J Exp Med 216:1891-1903 . https://doi.org/10.1084/jem.20182238

106. Sahin H, Trautwein C, Wasmuth HE (2010) Functional role of chemokines in liver disease models. Nat Rev Gastroenterol Hepatol 7:682-690 . https://doi.org/10.1038/nrgastro.2010.168

107. Saiman Y, Friedman S (2012) The Role of Chemokines in Acute Liver Injury. Front Physiol 3:213 . https://doi.org/10.3389/fphys.2012.00213

108. Marra F, Tacke F (2014) Roles for Chemokines in Liver Disease. Gastroenterology 147:577-594.e1. https://doi.org/10.1053/j.gastro.2014.06.043

109. Roehlen N, Crouchet E, Baumert TF (2020) Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives. Cells 9:. https://doi.org/10.3390/cells9040875

110. Oo YH, Shetty S, Adams DH (2010) The Role of Chemokines in the Recruitment of Lymphocytes to the Liver. Dig Dis 28:31-44 . https://doi.org/10.1159/000282062

111. Bhatia M, Zemans RL, Jeyaseelan S (2012) Role of Chemokines in the Pathogenesis of Acute Lung Injury. Am J Respir Cell Mol Biol 46:566-572 . https://doi.org/10.1165/rcmb.2011-0392TR

112. Chen H, Wang D, Wang X (2010) Role of Airway Epithelium-Origin Chemokines and their Receptors in COPD. J Epithel Biol Pharmacol 3:

 113. Barnes PJ (2016) Inflammatory mechanisms in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol 138:16-27 . https://doi.org/10.1016/j.jaci.2016.05.011

114. Henrot P, Prevel R, Berger P, Dupin I (2019) Chemokines in COPD: From Implication to Therapeutic Use. Int J Mol Sci 20: . https://doi.org/10.3390/ijms20112785

115. Keane MP (2008) The role of chemokines and cytokines in lung fibrosis. Eur Respir Rev 17:151-156 . https://doi.org/10.1183/09059180.00010908

116. Blease K, Lukacs NW, Hogaboam CM, Kunkel SL (2000) Chemokines and their role in airway hyper-reactivity. Respir Res 1:54-61 . https://doi.org/10.1186/rr13

117. El Mesallamy HO, Ahmed HH, Bassyouni AA, Ahmed AS (2012) Clinical significance of inflammatory and fibrogenic cytokines in diabetic nephropathy. Clin Biochem 45:646-650 . https://doi.org/10.1016/j.clinbiochem.2012.02.021.

 118. Gaballa M, Farag Y (2012) Predictors of diabetic nephropathy. Cent Eur J Med 8: . https://doi.org/10.2478/s11536-012-0055-3. https://doi.org/10.2478/s11536-012-0055-3

119. Lim AKH, Tesch GH (2012) Inflammation in Diabetic Nephropathy. In: Mediators Inflamm. https://www.hindawi.com/journals/mi/2012/146154/. Accessed 25 Sep 2020. https://doi.org/10.1155/2012/146154

120. Sanchez AP, Sharma K (2009) Transcription factors in the pathogenesis of diabetic nephropathy. Expert Rev Mol Med 11:e13 . https://doi.org/10.1017/S1462399409001057

121. Takebayashi K, Matsumoto S, Aso Y, Inukai T (2006) Association between circulating monocyte chemoattractant protein-1 and urinary albumin excretion in nonobese Type 2 diabetic patients. J Diabetes Complications 20:98-104 . https://doi.org/10.1016/j.jdiacomp.2005.05.008

122. Belkaid Y, Hand TW (2014) Role of the Microbiota in Immunity and Inflammation. Cell 157:121-141 . https://doi.org/10.1016/j.cell.2014.03.011

123. Garlet GP, Sfeir CS, Little SR (2014) Restoring Host-Microbe Homeostasis via Selective Chemoattraction of Tregs. J Dent Res 93:834-839 . https://doi.org/10.1177/0022034514544300

124. Zheng D, Liwinski T, Elinav E (2020) Interaction between microbiota and immunity in health and disease. Cell Res 30:492-506 . https://doi.org/10.1038/s41422-020-0332-7

125. Park UC, Kim TW, Yu HG (2014) Immunopathogenesis of Ocular Behçet's Disease. In: J. Immunol. Res. https://www.hindawi.com/journals/jir/2014/653539/. Accessed 13 Sep 2020. https://doi.org/10.1155/2014/653539

126. Frassanito MA, Dammacco R, Cafforio P, Dammacco F (1999) Th1 polarization of the immune response in Behçet's disease: a putative pathogenetic role of interleukin-12. Arthritis Rheum 42:1967-1974 . https://doi.org/10.1002/1529-0131(199909)42:9<1967::AID-ANR24>3.0.CO;2-Z.

 127. Houman H, Hamzaoui A, Ben Ghorbal I, Khanfir M, Feki M, Hamzaoui K (2004) Abnormal expression of chemokine receptors in Behçet's disease: relationship to intracellular Th1/Th2 cytokines and to clinical manifestations. J Autoimmun 23:267-273 . https://doi.org/10.1016/j.jaut.2004.07.005

128. Ahmed MB, Houman H, Miled M, Dellagi K, Louzir H (2004) Involvement of chemokines and Th1 cytokines in the pathogenesis of mucocutaneous lesions of Behçet's disease. Arthritis Rheum 50:2291-2295 .  https://doi.org/10.1002/art.20334

129. Imamura Y, Kurokawa MS, Yoshikawa H, Nara K, Takada E, Masuda C, Tsukikawa S, Ozaki S, Matsuda T, Suzuki N (2005) Involvement of Th1 cells and heat shock protein 60 in the pathogenesis of intestinal Behçet's disease. Clin Exp Immunol 139:371-378 . https://doi.org/10.1111/j.1365-2249.2005.02695.x

130. Dalghous AM, Freysdottir J, Fortune F (2006) Expression of cytokines, chemokines, and chemokine receptors in oral ulcers of patients with Behcet's disease (BD) and recurrent aphthous stomatitis is Th1-associated, although Th2-association is also observed in patients with BD. Scand J Rheumatol 35:472-475 . https://doi.org/10.1080/03009740600905380